Your patients with articular cartilage injuries of the knee, particularly those who have been recommended for microfracture treatment, may be eligible to participate in the NeoCart® Trial if they meet the following preliminary eligibility criteria (additional eligibility assessments will be necessary):
- Your patient is at least 18 and no more than 59 years of age.
- Your patient suffers from knee pain in one knee.
- Your patient has been diagnosed with a cartilage injury.
The summary of inclusion and exclusion criteria at www.clinicaltrials.gov can help guide physicians in referring the proper patients for this study. Study inclusion and exclusion criteria as well as other trial information is available.
Would you Like to Refer a Patient?
The NeoCart Clinical Trial was fully enrolled in June 2017 and is no longer enrolling patients.
Caution: New Biologic. Limited by Federal law to investigational use only and is not available for sale.